PHILADELPHIA, June 25, 2014 /PRNewswire/ --
Veteran cancer surgeon, author and patient empowerment advocate joins Elsevier Clinical Solutions management team
Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today that Peter Edelstein, MD, has joined the company as Chief Medical Officer.
"Dr. Edelstein brings deep clinical and business experience to our team at Elsevier," said Jay Katzen, President, Elsevier Clinical Solutions. "We will look for him to help us improve the way we engage with hospitals, health systems and other healthcare providers as they seek best-of-suite solutions to meet their workflow and evidence-based practice needs."Edelstein is board certified by the American College of Surgeons and the American Society of Colon and Rectal Surgery. He has more than 35 years of experience practicing medicine and in healthcare administration. Edelstein was in private practice for several years before serving on the surgical faculty at Stanford University, where he focused on gastrointestinal, oncologic and trauma surgery. He then spent more than a decade as an executive in the Silicon Valley medical device industry. Edelstein's most recent role was as Chief Medical Officer for the healthcare business at LexisNexis Risk Solutions, a Reed Elsevier company. He is also the author of the recently published book, 'Own Your Cancer: A Take-Charge Guide for the Recently Diagnosed & Those Who Love Them'. "Elsevier's reputation is well known and highly valued by care providers across the world, and the company is recognized by clinicians everywhere as a premier medical information provider," Edelstein said. "I look forward to working with our talented and knowledgeable teams and full range of clinical solutions as we tell the story of today's Elsevier. By applying my clinical and business experiences and perspectives, I hope to help Elsevier continue to grow and offer the best integrated solutions to our customers."
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV